Koers Accretive Health, Inc. Nyse
Aandelen
US00438V1035
Gezondheidszorgvoorzieningen & -diensten
slotkoers
Andere beurzen
|
||
- USD | - |
10/04 | R1 RCM INC. : KeyBanc Capital Markets haalt aandeel van kooplijst | ZM |
21/03 | R1 RCM INC. : Canaccord Genuity handhaaft koopadvies | ZM |
Omzet 2024 * | 2,64 mld. 2,47 mld. | Omzet 2025 * | 2,95 mld. 2,76 mld. | Marktkapitalisatie | 5,01 mld. 4,68 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - 0 | Nettowinst (verlies) 2025 * | 127 mln. 119 mln. | EV/omzet 2024 * | 2,59 x |
Nettoschuld 2024 * | 1,84 mld. 1,72 mld. | Nettoschuld 2025 * | 1,62 mld. 1,51 mld. | EV/omzet 2025 * | 2,25 x |
K/w-verhouding 2024 * |
-171
x | K/w-verhouding 2025 * |
53,8
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 34,94% |
Recentste transcriptie over Accretive Health, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lee Rivas
CEO | Chief Executive Officer | - | 22-06-22 |
Director of Finance/CFO | - | 21-06-22 | |
John Sparby
PSD | President | 48 | 01-01-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Anthony Tersigni
BRD | Director/Board Member | 74 | 12-08-19 |
David M. Dill
BRD | Director/Board Member | 55 | 18-04-21 |
Joseph Flanagan
BRD | Director/Board Member | 52 | 01-04-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,92% | 84,68 mld. | |
+13,30% | 81,12 mld. | |
+10,92% | 29,4 mld. | |
-12,71% | 16,73 mld. | |
-3,06% | 16,36 mld. | |
-2,63% | 14,92 mld. | |
-31,75% | 11,77 mld. | |
-1,42% | 11,72 mld. | |
+27,44% | 11,71 mld. |